Catalyst Wire Dossier Catalyst Wire Dossier

Oral contraceptive containing norgestimate and ethinylestradiol

norgestimate/ethinylestradiol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral contraceptive containing norgestimate and ethinylestradiol, covering 2012-05-21 to 2012-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol [Phase 1]

See pricing